[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ipsen Sa ADR (IPSEY)

Ipsen Sa ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 15,100,020
  • Shares Outstanding, K 335,258
  • Annual Sales, $ 4,446 M
  • Annual Income, $ 501,780 K
  • EBIT $ 0 M
  • EBITDA $ 1,415 M
  • 60-Month Beta 0.42
  • Price/Sales 3.54
  • Price/Cash Flow 7.96
  • Price/Book 3.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/12/26
  • Annual Dividend & Yield (Fwd) 0.26 (0.59%)
  • Most Recent Dividend 0.302 on 06/04/26
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.2022 +4.25%
on 06/02/26
51.1000 -11.86%
on 05/05/26
-4.0450 (-8.24%)
since 04/30/26
3-Month
43.0900 +4.53%
on 03/23/26
51.1000 -11.86%
on 05/05/26
-0.8500 (-1.85%)
since 03/03/26
52-Week
28.6550 +57.18%
on 06/23/25
51.1000 -11.86%
on 05/05/26
+14.5900 (+47.91%)
since 06/04/25

Most Recent Stories

More News
National Survey From Ipsen Shows Young People Are Not Prepared for the Shift From Pediatric to Adult Healthcare

Survey underscores the need for more resources, better preparation Ipsen's Healthcare-Shift.com offers a conversation guide, transition checklists and other...

IPN : 34.71 (-0.54%)
IPSEY : 45.0400 (+2.71%)
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvayâ„¢ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

/CNW/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

IPN : 34.71 (-0.54%)
IPSEY : 45.0400 (+2.71%)
Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U.

Regulatory News:

OTC.VN : 0.560 (+3.70%)
IPN : 34.71 (-0.54%)
IPSEY : 45.0400 (+2.71%)
Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI

Regulatory News:

OTC.VN : 0.560 (+3.70%)
IPN : 34.71 (-0.54%)
IPSEY : 45.0400 (+2.71%)
Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

CINC : 29.06 (-0.48%)
AZN : 185.95 (+2.28%)
ALBO : 44.15 (-0.23%)
IPSEY : 45.0400 (+2.71%)
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Albireo Pharma, Inc....

ALBO : 44.15 (-0.23%)
IPSEY : 45.0400 (+2.71%)
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday

The market is moving higher, and these small companies are helping.

COMP : 7.71 (-2.16%)
$NASX : 25,709.43 (-4.18%)
DCT : 18.99 (unch)
ALBO : 44.15 (-0.23%)
IPSEY : 45.0400 (+2.71%)
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Regulatory News:

OTC.VN : 0.560 (+3.70%)
ALBO : 44.15 (-0.23%)
IPN : 34.71 (-0.54%)
IPSEY : 45.0400 (+2.71%)
Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva

Regulatory News:

OTC.VN : 0.560 (+3.70%)
IPN : 34.71 (-0.54%)
IPSEY : 45.0400 (+2.71%)
Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy

Regulatory News:

OTC.VN : 0.560 (+3.70%)
IPN : 34.71 (-0.54%)
IPSEY : 45.0400 (+2.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.

See More

Key Turning Points

3rd Resistance Point 45.0400
2nd Resistance Point 45.0400
1st Resistance Point 45.0400
Last Price 45.0400
1st Support Level 45.0400
2nd Support Level 45.0400
3rd Support Level 45.0400

See More

52-Week High 51.1000
Last Price 45.0400
Fibonacci 61.8% 42.5260
Fibonacci 50% 39.8775
Fibonacci 38.2% 37.2290
52-Week Low 28.6550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.